主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GALT
#3040
Galectin Therapeutics Inc.
2.9
8
-1.32%
版块:
基础:
利润货币:
日范围
年范围
日变化
-1.32%
每月变动
-5.40%
6个月变化
-25.87%
年变化
+104.11%
前一天收盘价
3.0
2
Open
2.9
8
Bid
Ask
Low
2.9
8
High
2.9
8
交易量
21
市场
股票
医疗保健
GALT
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
57.16 M
59.36 M
59.44 M
61.9 M
63.18 M
—
Valuation ratios
Enterprise value
101.41 M
83.75 M
52.06 M
82.55 M
66.88 M
521.06 M
Price to earnings ratio
—
-3.98
-1.82
-2.35
-1.7
-13.87
Price to sales ratio
—
877.9
125.82
242.31
136.7
146.11
Price to cash flow ratio
—
-4.98
-2.26
-3.18
-1.92
-16.37
Price to book ratio
—
331.01
-2.04
-1.68
-0.76
-1.84
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.79
0.73
1.82
1.46
2.69
2.81
Return on equity %
1.04
34.18
1.14
0.66
0.45
0.33
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
100
100
100
100
400
Operating margin %
—
21.87 K
6 885.46
8 812.96
7 216.5
31.11 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
22.12 K
6 961.58
9 506.02
8 001.19
38.53 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.46
4.63
1.58
1.77
0.49
2.1
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
0.02
0.02
0.03
0.19
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
0.42
0.52
0.55
0.67
0.49
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
0.68
0.31
0.43
0.24
0.76
Net current asset value per share
—
0.71
0.35
0.46
0.28
0.87
Tangible book value per share
—
0.01
0.56
1.02
1.67
7.28
Working capital per share
—
0.56
0.13
0.2
-0.29
-3.75
Book value per share
—
0.01
0.56
1.02
1.67
7.28
新闻
Galectin Therapeutics董事Marc Rubin辞去董事会职务
Galectin Therapeutics director Marc Rubin resigns from board
嘉莱科特治疗公司CFO出售价值23.3万美元股票
Galectin Therapeutics CFO sells $233k in shares
Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains
oracle, micron tech among market cap stock movers on friday
Galectin Therapeutics股价在FDA反馈药物进展后暴跌
Galectin Therapeutics stock plummets after FDA feedback on drug
FDA provides feedback on Galectin’s belapectin development program
Galectin Therapeutics董事出售价值105万美元股份
Galectin Therapeutics股东选举董事会成员并批准关键提案
Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data (NASDAQ:GALT)